the use of sodium-glucose cotransporter-2 (sglt2) inhibitors in stemi - weekly research conference
Published 1 year ago • 1.6K plays • Length 49:58Download video MP4
Download video MP3
Similar videos
-
50:30
protocols for safe use of sglt2i and glp1ra in the hospital setting
-
24:33
sodium glucose cotransporter 2 inhibitors in heart failure with reduced ejection fraction
-
3:16
using sodium glucose cotransporter 2 (sglt2) inhibitors to manage heart failure
-
1:06:15
a tale of salt and sugar: sglt2 inhibitors in cardiovascular disease
-
7:53
dr su ern yeoh - sglt2 inhibitors in heart failure and diuretic resistance
-
12:49
esc tv conversations - sglt2 inhibitors – wonder drugs in heart failure and beyond?
-
13:40
e139 – sglt2 inhibitors for kidney and heart disease
-
6:57
how does dapagliflozin work? understanding sglt2 inhibitors.
-
10:55
what are sglt2 inhibitors and how do they affect kidney disease?
-
15:35
field notes ep. 19 | slowing down progression of ckd - sglt2 inhibitors with dr. robert kossmann
-
1:06:11
iscp 2021 dapagliflozin et al. the growing therapeutic spectrum of sglt2i
-
1:06:33
heart failure with preserved ejection fraction: five common myths - grand rounds with james fang, md
-
1:36
sglt (sodium glucose linked transporter)
-
3:44
breaking news: sglt2i in acute heart failure
-
51:52
the serendipitous story of sglt2i in the treatment of heart failure
-
5:16
what is ablation?
-
1:26
the future of telestration, chip by surgease innovations
-
2:40
the cellular actions of sglt2i's
-
51:04
dr. jamie falk: a deep dive into sglt2 inhibitors for individual patients with diabetes
-
2:29
department of molecular medicine and therapeutics | osuccc – james
-
1:00
sglt (sodium glucose linked transporter)